Years of potential life lost due to malignant pleural mesothelioma in Turkey

S. Metintas (Eskisehir, Turkey), G. Ak (Eskisehir, Turkey), M. Metintas (Eskisehir, Turkey)

Source: International Congress 2019 – Indoor and outdoor air quality considerations
Session: Indoor and outdoor air quality considerations
Session type: Thematic Poster
Number: 4446
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Metintas (Eskisehir, Turkey), G. Ak (Eskisehir, Turkey), M. Metintas (Eskisehir, Turkey). Years of potential life lost due to malignant pleural mesothelioma in Turkey. 4446

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mesothelioma in situ with regressive malignant pleural effusion. A year latter
Source: Virtual Congress 2021 – CCC Thoracic oncology
Year: 2021


Management of malignant pleural mesothelioma in 2017
Source: ERS Skills course - Medical thoracoscopy
Year: 2017

Malignant pleural mesothelioma (MPM) – 5 years of experience
Source: Eur Respir J 2006; 28: Suppl. 50, 91s
Year: 2006

Malignant pleural mesothelioma clinical aspects and survival in 93 cases
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010

Management of malignant pleural mesothelioma
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016

Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015

Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012

Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014

Survival time in patients with malignant pleural mesothelioma
Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Year: 2007


Variation in incidence trends of malignant pleural mesothelioma in Europe
Source: Eur Respir J, 51 (2) 1702384; 10.1183/13993003.02384-2017
Year: 2018



Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017


Non-malignant pleural disease from asbestos and malignant pleural mesothelioma
Source: Eur Respir Monogr 2020; 89: 141-149
Year: 2020


What outcome after pleurodesis in malignant pleural effusion in lung cancer?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Treatment of malignant pleural mesothelioma: dilemmas
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005

Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Drain site radiotherapy in malignant pleural mesothelioma: a wasted resource
Source: Eur Respir J 2007; 30: 1021
Year: 2007